Latest Articles

Publication Date
All News Scientific
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Yahoo Finance

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Yahoo Finance

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Forget IVF, Here’s a More Ethical Way to Treat Fertility - lifenews.com

Forget IVF, Here’s a More Ethical Way to Treat Fertility lifenews.com

Published: Oct. 17, 2025, 8:57 p.m.
Read Full Article
Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer - OncLive

Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer OncLive

Published: Oct. 15, 2025, 12:10 p.m.
Read Full Article
'No one’s really listening' Health service accused of 'disgusting' treatment of women - EVOKE

'No one’s really listening' Health service accused of 'disgusting' treatment of women EVOKE

Published: Oct. 15, 2025, 8:59 a.m.
Read Full Article
Startup, ENDOless: Artificial Intelligence and Data to Treat Endometriosis - Materia Rinnovabile | Renewable Matter

Startup, ENDOless: Artificial Intelligence and Data to Treat Endometriosis Materia Rinnovabile | Renewable Matter

Published: Oct. 15, 2025, 7:51 a.m.
Read Full Article
Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog - FMIBlog

Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog FMIBlog

Published: Oct. 15, 2025, 6:44 a.m.
Read Full Article
“We’ve spent $100k on fertility treatment and still don’t have a baby” - MSN

“We’ve spent $100k on fertility treatment and still don’t have a baby” MSN

Published: Oct. 14, 2025, 5:13 p.m.
Read Full Article
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer

Published: Oct. 14, 2025, 2:41 p.m.
Read Full Article
Exploring the Mechanism of Zishen Quyu Jiedu Formula in Treating Endometriosis Based on Network Pharmacology and Experimental Verification - Frontiers

Exploring the Mechanism of Zishen Quyu Jiedu Formula in Treating Endometriosis Based on Network Pharmacology and Experimental Verification Frontiers

Published: Oct. 14, 2025, 8:51 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!